|
|
||||||||
1 The Cardiovascular Institute, Earlier work from this laboratory showed that
abnormal fibroblast phenotypes isolated from fibrotic human lung
produce factor(s) capable of inducing apoptosis and necrosis of
alveolar epithelial cells in vitro [B. D. Uhal, I. Joshi, A. True, S. Mundle, A. Raza, A. Pardo, and M. Selman. Am.
J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L819-L828, 1995]. To determine
whether epithelial cell death is associated with proximity to abnormal
fibroblasts in vivo, the spatial distribution of epithelial cell loss,
DNA fragmentation, and myofibroblasts was examined in the same tissue specimens used previously for fibroblast isolation. Paraffin sections of normal and fibrotic human lung were subjected to in situ end labeling (ISEL) of fragmented DNA and simultaneous immunolabeling of
cuboidalization; type II pneumocytes; programmed cell death; contractile interstitial cells
THE CELLULAR AND MOLECULAR EVENTS leading to
fibrogenesis in the lung are believed to be intimately related to
alveolitis and alveolar epithelial repair processes (11).
Investigations of the damage caused by hyperoxic gas on murine whole
lung tissue (2) or explants derived from such tissue (3) were the first to suggest that repair of alveolar epithelial damage was critical for
healing without fibrosis. Subsequent studies (17, 18) of the ability of
oxygen to potentiate lung damage induced by butylated hydroxytoluene
supported the hypothesis that the severity of fibrogenesis was
inversely related to the efficiency of alveolar epithelial repair.
Consistent with that theory is the observation that foci of
accumulating fibroblasts in human lung tissue are found in close
proximity to unrepaired or abnormal alveolar epithelium (22).
In the fibrotic human lung and in animal models of pulmonary fibrosis,
the alveolar epithelium can be absent or metaplastic and often is
primarily cuboidal rather than the normal mixture of squamous type I
cells interspersed with cuboidal type II cells (11, 33). Electron
microscopy of human tissue suggests that the cuboidal cells are of both
alveolar and bronchiolar origin (21), but the relative importance of
alveolar versus bronchial cells in the genesis of new alveolar
epithelium has not been explored rigorously. For many years, it has
been believed that the cuboidal epithelium is composed of rapidly
proliferating cells that are attempting to repair the denuded
epithelium (11, 21, 26). It has been suggested that the high ratio of
cuboidal to squamous cells in the abnormal epithelium might be due to
an inability of dividing type II cells to differentiate into type I
cells, possibly as a result of altered composition or integrity of the underlying extracellular matrix (26).
Earlier work from this laboratory (38) demonstrated that fibroblasts
isolated from fibrotic human or rat lung produce factor(s) capable of
inducing apoptosis and necrosis of alveolar epithelial cells in vitro.
These observations suggested that apoptosis might be an important
mechanism of epithelial cell death in the fibrotic lung. Consistent
with that theory, apoptotic alveolar epithelial cells have been
recently observed in sections of fibrotic lung of both human and mouse
origin (15, 24). We hypothesized that the abnormal
fibroblast phenotypes that emerge in fibroblastic foci might constitute
an important source of factor(s) capable of inducing epithelial cell
apoptosis. In the lung, these phenotypes are known to include the
myofibroblast subtype termed "VA" that expresses the intermediate
filaments vimentin and Materials. Monoclonal
antibodies to Tissue samples and handling. Human
lung tissue was obtained by open lung biopsies performed at the
National Institute of Respiratory Diseases (Tlalpan, Mexico). Lung
tissue was obtained from six patients with idiopathic pulmonary
fibrosis (IPF). All patients had clinical, functional, and radiological
features that fulfill the diagnostic criteria for an interstitial lung
disease (29, 32). Briefly, all had progressive dyspnea,
bilateral reticulonodular images on chest roentgenogram, restrictive
lung functional impairment with decreased lung volumes and compliance,
and hypoxemia at rest that worsened with exercise. Patients with IPF
had neither antecedents of any occupational or environmental exposure
nor other known cause of interstitial lung disease; samples from these
patients were the same as those designated human IPF
(HIPF) in the earlier study by Uhal et al. (38) of primary fibroblasts
isolated from fibrotic human and rat lung tissue. Normal lung tissue
was obtained from three individuals having a lobectomy for removal of a
primary lung tumor. No histopathological evidence of disease was found in those tissue samples. All tissue was fixed in 10% neutral-buffered Formalin for 16 h and embedded in paraffin. Sections were cut at
6.0-µm thickness and mounted on glass coverslips.
In situ end labeling and
immunohistochemistry. Tissue sections were
deparaffinized by being passed through xylene, 1:1 xylene-alcohol, 100% alcohol, and 70% alcohol for 10 min each. In situ end labeling (ISEL) of fragmented DNA was conducted by a modification of the method
of Mundle et al. (27). Briefly, ethanol was removed by rinsing in
distilled water for at least 10 min. The coverslips were then placed in
0.23% periodic acid (Sigma) for 30 min at 20°C. Samples were
rinsed once in water and three times in 0.15 M phosphate-buffered
saline (PBS) for 4 min each and were then incubated in saline-sodium
citrate solution (0.3 M NaCl and 30 mM sodium citrate in water, pH 7.0)
at 80°C for 20 min. After four rinses in PBS and four rinses in
buffer A (50 mM
Tris · HCl, 5 mM
MgCl2, 10 mM For double labeling with ISEL and antibodies to Identification of collagen. Collagens
were localized through staining of lung sections by the picrosirius red
technique (30). Briefly, sections deparaffinized with xylene were
rehydrated through a descending series of ethanols to distilled water.
The hydrated sections were immersed in 0.2% aqueous phosphomolybdic
acid for 2 min, rinsed in distilled water, and then stained for 110 min with 0.1% sirius red F3BA (Pfaltz and Bauer, Stamford, CT) in saturated aqueous picric acid, pH 2.0. The sections were washed for 2 min in 0.01 N HCl, rinsed for 45 s in 70% ethanol, dehydrated in three
changes of absolute alcohol, cleared in xylene, and mounted in
Permount. Fibrotic foci were detected by polarization microscopy, under
which collagen fibers appear yellow-red (30) or white in gray-scale images.
Microscopy and image analysis. The
prepared sections were photographed under transmitted, epifluorescent,
or polarized light on an Olympus BH2 epifluorescence microscope fitted
with automatic photographic equipment. For electron microscopy,
portions of some biopsies were fixed in 1% gluteraldehyde in
cacodylate buffer. The tissues were osmicated and stained with uranyl
acetate, dehydrated with a graded series of alcohol solutions, and
embedded in Epon/Araldite. Thin sections were examined and photographed
on a Philips EM 300 instrument in the Electron Microscopy Facility,
Rush Medical College (Chicago, IL).
For image analysis of ISEL and For analyses of the relationship between epithelial cell death and
immunoreactivity to
![]()
ABSTRACT
Top
Abstract
Introduction
Methods
Results
Discussion
References
-smooth muscle actin (
-SMA); replicate samples were subjected to
electron microscopy and detection of collagens by the picrosirius red
technique. Normal human lung exhibited very little labeling except for
positive
-SMA immunoreactivity of smooth muscle surrounding bronchi
and vessels. In contrast, fibrotic human lung exhibited moderate to
heavy ISEL of interstitial, cuboidal epithelial, and free alveolar
cells. ISEL of the alveolar epithelium was not distributed uniformly
but was most intense immediately adjacent to underlying foci of
-SMA-positive fibroblast-like interstitial cells. Both electron
microscopy and picrosirius red confirmed epithelial cell apoptosis,
necrosis, and cell loss adjacent to foci of collagen accumulation
surrounding fibroblast-like cells. These results demonstrate that the
cuboidal epithelium of the fibrotic lung contains dying as well as
proliferating cells and support the hypothesis that alveolar epithelial
cell death is induced by abnormal lung fibroblasts in vivo as it is in vitro.
![]()
INTRODUCTION
Top
Abstract
Introduction
Methods
Results
Discussion
References
-smooth muscle actin (
-SMA) (23).
Accordingly, we further theorized that the cuboidal epithelium might
contain apoptotic and/or necrotic cells in addition to
proliferating cells, particularly in proximity to the VA fibroblast
subtype. To test this hypothesis, we examined the distribution of dying
cells within the cuboidal epithelium relative to underlying fibrotic
foci in the same biopsy samples that we used earlier for fibroblast
isolation (38). We report that the cuboidal epithelium of fibrotic
human lung contains apoptotic and necrotic cells in close proximity to
foci of
-actin-positive fibroblasts and collagen accumulation.
![]()
METHODS
Top
Abstract
Introduction
Methods
Results
Discussion
References
-SMA (clone 1A4) and biotinylated dUTP were obtained
from Sigma Immunochemicals (St. Louis, MO). DNA polymerase I was
obtained from Promega (Madison, WI). Solutions
A and B of the
Vectastain ABC Elite formulation were purchased from Vector
Laboratories (Burlingame, CA). All other materials were of reagent grade.
-mercaptoethanol,
and 0.005% BSA in water, pH 7.5), the coverslips were incubated at
18°C for 2 h with ISEL solution (0.001 mM biotinylated dUTP, 20 U/ml of DNA polymerase I, and 0.01 mM each dATP, dCTP, and dGTP in
buffer A). Afterward, the sections
were rinsed thoroughly five times with buffer
A and three additional times in 0.5 M PBS. For
detections based on diaminobenzidine, the tissue was then incubated at
20°C with a solution consisting of 80 µl each of
solutions A (avidin
solution) and B (biotin-peroxidase solution) of the Vectastain Elite Kit in 3.84 ml of
buffer B (1% BSA and 0.5% Tween 20 in 0.5 M PBS). After 30 min, the sections were washed four times in PBS
and were then immersed for 10 min in a solution of 0.25 mg/ml of
diaminobenzidine in 0.05 M Tris · HCl, pH 7.5, containing 0.01% hydrogen peroxide. Alternatively, detection of
incorporated dUTP was achieved with a fast blue chromogen system. The
tissues were rinsed in distilled water three times and mounted under
Fluoromount solution (Southern Biotechnology Associates, Birmingham, AL).
-SMA, fluorescein
(FITC)-conjugated monoclonal antibodies to
-actin were diluted 1:100
in ISEL solution and incubated with the tissue as described above for
single ISEL. Control samples, treated as described above but without
DNA polymerase I, gave no positive signal (data not shown).
-SMA labeling, transmitted light and
fluorescence digital images were obtained by scanning color
photographic slides made with tungsten film. Scanned images were first
converted to 256-level gray scale, then to pseudocolor on the basis of
intensity thresholds derived by dividing each 256-level gray scale into
three equal levels of intensity (low, moderate, and high). Once
established, the same intensity thresholds were applied to all images
processed for colocalization studies (see Fig. 5).
-SMA (Table 1), ISEL
or
-SMA intensity thresholds were defined as described above. The
property of epithelial integrity was defined as the presence of
morphologically intact epithelium within 50 µm of any border of the
-SMA intensity threshold under evaluation. In the compilation of
data from a series of lung sections (Table 1), the scale for scoring
epithelial integrity was from zero to five marks (from least to
highest, respectively). A score of zero marks indicates complete
absence of epithelial cells overlying the stroma within 50 µm of the
indicated
-SMA threshold. A score of five marks reflects
morphologically intact epithelium within the entire scoring region.
Table 1.
Relationship of epithelial integrity and ISEL to
-actin-positive interstitium
The scale for scoring ISEL intensity also was from zero to five marks
(from least to highest, respectively). In the compiled intensity data,
a score of zero marks indicates that all epithelial cells within the
50-µm limit defined above display no ISEL. A score of five marks
indicates that all epithelial cells within the 50-µm limit display
the highest ISEL intensity. Regions in which both ISEL and
-SMA
labels exactly colocalized were scored at the highest ISEL intensity.
Processing of scanned images was performed with MOCHA image-analysis
software (Jandel Scientific, San Raphael, CA). The scoring of samples
from IPF patients was performed in a blinded fashion.
| |
RESULTS |
|---|
|
|
|---|
The histology of normal and fibrotic lung specimens is shown in Fig. 1, A-C. Tissue from patients with IPF showed patchy alveolar septal fibrosis and interstitial inflammation consisting mostly of mononuclear cells but also of neutrophils and eosinophils. A variable macrophage accumulation was observed in the air spaces as was cuboidalization of the alveolar epithelium. Biopsies lacked granulomas, vasculitis, microorganisms, and inorganic material by polarized light microscopy (4).
|
ISEL of fragmented DNA in sections of normal human lung tissue revealed very few labeled cells (Fig. 1D). In contrast, sections prepared from lung tissue of patients with IPF (Fig. 1E) contained many labeled cells within the interstitium, air spaces, and epithelium. Electron microscopy of the alveolar epithelium revealed cells with morphological characteristics of both apoptosis and necrosis (Fig. 2, B and C); dying epithelial cells were often observed in locations adjacent to fibrotic foci containing numerous collagen bundles (Fig. 2B, CB) interspersed with fibroblast-like interstitial cells (Fig. 2C, F).
|
Staining of lung sections by the picrosirius red technique (Fig. 3) confirmed the presence of collagen in these foci and suggested a relationship between the locations of fibrotic foci and epithelial cell death. The condensed nuclei of apoptotic cells were found within the epithelium near regions of moderate accumulation of collagen (Fig. 3C); the epithelium adjacent to regions of very dense collagen accumulation was clearly injured and often absent (Fig. 3E).
|
To determine whether alveolar epithelial cell death was related to the
proximity of the affected epithelium to abnormal interstitial cells
within the fibrotic foci, double labeling of fibrotic lung specimens
was performed with ISEL and simultaneous immunolabeling of
-SMA. The
specificity of the antibodies to
-SMA was demonstrated first with
sections of normal human lung, in which immunoreactivity was found only
within the smooth muscle underlying vessels or bronchi (Fig.
4). In contrast, sections of fibrotic human
lung were immunoreactive to anti-
-SMA in numerous fibroblastic foci scattered throughout the parenchyma; one of these foci is displayed in
Fig. 5. The
-SMA labeling (Fig.
5B) was extensive in the
interstitium immediately underlying "sheets" of in situ
end-labeled cuboidal epithelium (Fig.
5A, arrowheads). In isolated areas
corresponding to the most intense
-SMA immunoreactivity (Fig.
5C, green areas), the adjacent
alveolar epithelium was absent or partially detached from the
underlying stroma (arrows).
|
|
The pseudocolor image (Fig. 5C)
displays three intensity threshold levels for both ISEL (white, red,
and blue) and
-SMA labeling (white, yellow, and green), constructed
from images of each label analyzed individually. These thresholds were
used to obtain a semiquantitative evaluation of the relationship
between the two labels in a series of fibrotic lung samples. Table 1
displays the results of this analysis. Scoring of epithelial integrity, defined as the presence of intact epithelium within 50 µm of
-actin immunoreactivity, revealed that the most damaged or absent
epithelia were those in close proximity to interstitia that reacted
most intensely with
-SMA antibodies (
-SMA intensity level 3, green). The remaining epithelial cells were then scored on the basis of ISEL intensity as defined in the pseudocolor image; the most intense ISEL of epithelia was found adjacent to foci of the most intense
-SMA labeling. The epithelial layer adjacent to interstitia of light
or absent
-SMA immunoreactivity (intensity level 1, white) was of
higher integrity and relatively free of ISEL.
| |
DISCUSSION |
|---|
|
|
|---|
It is generally accepted that alveolitis and damage to the alveolar epithelium are important antecedents of fibrogenesis in the lung. As discussed by Crystal et al. (11), data supporting this concept come from both animal models and studies of familial cases of IPF in which the children of afflicted parents exhibit alveolitis well before clinical evidence of the disease (7). In studies of intact animal models, the experimental inhibition of alveolar repair in mice previously injured with butylated hydroxytoluene led to an acceleration of fibrogenesis (17, 18). Similarly, mouse lung explants with severe epithelial damage induced by prior hyperoxic lung injury exhibited marked interstitial cell proliferation and collagen deposition in culture, but explants of less severely injured tissue did not (3). As detailed by Witschi (39), these observations suggested that the critical determinant in the pathway to fibrogenesis was not the infiltrating inflammatory cells but rather the epithelial damage and its repair. Alveolar epithelial repair normally occurs through the proliferation and differentiation of type II alveolar epithelial cells, a process that is believed to be regulated by factors produced by lung fibroblasts (25, 28). The many important "antifibrotic" functions of the intact alveolar epithelium have been discussed in detail by Simon (35).
Cuboidalization of the alveolar epithelium is a common feature of the fibrotic lung regardless of the animal species or the initiating stimuli (11, 33, 35). Numerous investigations (1, 13, 19, 20) of animal models of lung injury have documented a transient cuboidalization as type II pneumocytes proliferate to replace damaged or lost type I cells. Largely on the basis of these observations, it has been presumed that epithelial cuboidalization in the fibrotic human lung is indicative of sustained epithelial proliferation in the absence of appropriate factors to signal the cessation of cell division and the initiation of subsequent differentiation (26, 35). This interpretation, however, fails to consider other possible mechanisms underlying cuboidalization, such as reversion of type I cells into type II cells by transdifferentiation (12, 34) or rapid loss of type I cells by apoptosis (37, 38).
Apoptotic cells were observed in the bronchial and alveolar epithelia of mice made fibrotic by intratracheal administration of bleomycin (15); the apoptotic cells appeared 1 day after bleomycin administration and reappeared during the progression of fibrosis at days 7-14 after administration. Although bleomycin is known to induce apoptosis in isolated alveolar macrophages (16), it is not clear whether the agent induces apoptosis directly on alveolar epithelial cells, and thus it is unknown whether epithelial cell apoptosis is a common mechanism underlying fibrogenesis in the mouse lung or an unrelated consequence of direct damage by bleomycin. On the other hand, ligation of Fas antigen with antibodies to Fas induced epithelial apoptosis and pulmonary fibrosis in mice, suggesting involvement of apoptosis in the pathogenesis of pulmonary fibrosis (14).
Our work suggests that the cuboidal epithelium of fibrotic human lung contains dying as well as proliferating cells, at least during the late stage of disease progression at which the tissue biopsies were obtained. Although the study of samples from advanced fibrotic lung may not yield information relevant to early events in the pathogenesis of fibrosis, we contend that the contribution of epithelial cell death to failure of epithelial repair likely deepens and extends the committment to fibrogenesis. As discussed by Simon (35), intact alveolar epithelium produces prostaglandins of the E series, known inhibitors of fibroblast proliferation (6, 10), and protects underlying interstitial cells from exposure to growth factors released by intra-alveolar macrophages and other inflammatory cells. For these reasons, failure of the epithelium to repair may be equally detrimental in advanced fibrosis as well as in the genesis of nascent fibrotic foci. In this study, the finding of apoptotic and necrotic epithelial cells overlying fibroblastic foci in the particular specimens examined is consistent with the earlier study by Uhal et al. (38) of factors produced by fibroblasts isolated from the same biopsy samples.
Our data also confirm the observations of Kuwano et al. (24) that DNA fragmentation and apoptosis in the alveolar epithelium are prominent features of fibrotic human lung tissue with no known prior exposure to bleomycin or other potential xenobiotic inducers of apoptosis. Apoptosis of mesenchymal cells is believed to constitute an important and necessary component of the resolution of granulation tissue in the lung (31); intuitively, apoptotic cells would be expected in a grossly hypercellular tissue that is attempting to restore normal architecture. The notion that excess alveolar epithelial cells are also eliminated by programmed cell death is supported by the recent study of Bardales et al. (5), who found that apoptotic alveolar epithelial cells were relatively abundant in the lungs of patients with resolving acute lung injury but not in tissue samples taken during the proliferative phase of chronic interstitial pneumonia. Those findings are in contrast to the data of Hagimoto and colleagues (14, 15), which suggest a role for apoptosis in the genesis of fibrosis as well as in its resolution.
Abnormal epithelial-mesenchymal interactions in lung injury were first
speculated to be important on the basis that unusual cell contacts
between fibroblasts and alveolar epithelial cells were observed in
butylated hydroxytoluene-injured mouse lung and in lung tissue from
patients with IPF (8). In the human lung, the predominant fibroblast
subtype that emerges in fibroblastic foci has been designated as the
subtype VA, which expresses the intermediate filaments vimentin and
-SMA and has been termed the myofibroblast (23). This subtype may be
the same as that identified by immunoreactivity to anti-pC1, which
recognizes the COOH-terminal polypeptide of human procollagen type I;
pC1-positive cells were found adjacent to regions of severe epithelial
shedding or cuboidalization in lung tissue from patients with IPF (22). In light of the earlier study (38) of fibroblasts derived
from the same specimens studied here, our findings of apoptotic
epithelial cells in proximity to
-SMA-positive interstitial cells in
situ suggests a role for the VA fibroblast subtype in the induction of
epithelial cell death in vivo. Characterization of the primary fibroblast strains and the proteins they secrete is currently underway.
In summary, electron microscopy and ISEL of fragmented DNA revealed
that the cuboidal epithelium of fibrotic human lung is composed of both
proliferating and dying cells. ISEL and simultaneous immunolabeling for
-SMA revealed that apoptotic and necrotic epithelial cells were
observed primarily in proximity to underlying foci of
-actin-positive interstitial cells. These results are consistent
with a role for the myofibroblast in the production of inducers of
epithelial cell apoptosis and necrosis. We speculate that this abnormal
epithelial-mesenchymal interaction contributes to the pathogenesis
and/or exacerbation of fibrotic lung disease by preventing
normal epithelial repair and thereby deepening the commitment to fibrogenesis.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by National Heart, Lung, and Blood Institute Grant HL-45136 to B. D. Uhal and by Instituto Nacional de Enfermedades Respiratorias, (Tlalpan, Mexico).
| |
FOOTNOTES |
|---|
Address for reprint requests: B. D. Uhal, The Cardiovascular Institute, Michael Reese Hospital, 2929 S. Ellis Ave., Rm. 405KND, Chicago, IL 60616.
Received 27 May 1997; accepted in final form 27 August 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adamson, I. Y. R.,
and
D. H. Bowden.
The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen.
Lab. Invest.
30:
35-42,
1974[Medline].
2.
Adamson, I. Y. R.,
and
D. H. Bowden.
Pulmonary injury and repair. Organ culture studies of murine lung after oxygen.
Arch. Pathol. Lab. Med.
100:
640-643,
1976[Medline].
3.
Adamson, I. Y. R.,
L. Young,
and
D. H. Bowden.
Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis.
Am. J. Pathol.
130:
377-383,
1988[Abstract].
4.
Antoniades, H. N.,
M. Bravo,
R. E. Avila,
T. Galanopoulus,
J. Neville-Golden,
M. Maxwell,
and
M. Selman.
Platelet-derived growth factor in idiopathic pulmonary fibrosis.
J. Clin. Invest.
86:
1055-1064,
1990.
5.
Bardales, R. H.,
S. S. Xie,
R. F. Schaefer,
and
S. Hsu.
Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury.
Am. J. Pathol.
149:
845-852,
1996[Abstract].
6.
Barile, F.,
R. Ripley,
Z. Siddiqi,
and
R. Bienkowski.
Effects of prostaglandin E1 on collagen production and degradation in human fetal lung fibroblasts.
Arch. Biochem. Biophys.
265:
441-446,
1988[Medline].
7.
Bitterman, P. B.,
S. I. Rennard,
B. A. Keogh,
M. D. Wewers,
S. Adelberg,
and
R. G. Crystal.
Familial idopathic pulmonary fibrosis: evidence of lung inflammation in unnaffected family members.
N. Engl. J. Med.
314:
1343-1347,
1986[Abstract].
8.
Brody, A. R.,
P. Soler,
F. Basset,
W. M. Haschek,
and
H. Witschi.
Epithelial-mesenchymal associations of cells in human pulmonary fibrosis and in BHT-oxygen-induced fibrosis in mice.
Exp. Lung Res.
2:
207-220,
1981[Medline].
9.
Bursch, W.,
S. Patte,
B. Putz,
G. Barthel,
and
R. Schulte-Hermann.
Determination of the length of the histological stages of apoptosis in normal liver and altered hepatic foci of rats.
Carcinogenesis
11:
847-853,
1990
10.
Chaucey, J. G.,
G. M. Peters,
and
R. H. Simon.
Arachidonic acid metabolism by rat alveolar epithelial cells.
Lab. Invest.
58:
133-140,
1988[Medline].
11.
Crystal, R. G.,
V. J. Ferrans,
and
F. Basset.
Biologic basis of pulmonary fibrosis.
In: The Lung: Scientific Foundations, edited by R. G. Crystal,
and J. B. West. New York: Raven, 1991, chapt. 7.8.1, p. 2031-2046.
12.
Danto, S. I.,
J. M. Shannon,
Z. Borok,
S. M. Zabski,
and
E. D. Crandall.
Reversible transdifferentiation of alveolar epithelial cells.
Am. J. Respir. Cell Mol. Biol.
12:
497-502,
1995[Abstract].
13.
Evans, M. J.,
L. J. Cabral,
R. J. H. Stephens,
and
G. Freeman.
Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2.
Exp. Mol. Pathol.
22:
142-150,
1975[Medline].
14.
Hagimoto, N.,
K. Kuwano,
H. Miyazaki,
R. Kunitake,
M. Fujita,
M. Kawasaki,
Y. Kanika,
and
N. Hara.
Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen.
Am. J. Respir. Cell Mol. Biol.
17:
272-278,
1997
15.
Hagimoto, N.,
K. Kuwano,
Y. Nomoto,
R. Kunitake,
and
N. Hara.
Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice.
Am. J. Respir. Cell Mol. Biol.
16:
91-101,
1997[Abstract].
16.
Hamilton, R.,
L. Li,
T. Felder,
and
A. Holian.
Bleomycin induces apoptosis in human alveolar macrophages.
Am. J. Physiol.
269 (Lung Cell. Mol. Physiol. 13):
L318-L325,
1995
17.
Haschek, W. M.,
K. M. Reiser,
A. J. P. Klein-Szanto,
J. A. Last,
and
H. P. Witschi.
Potentiation of butylated hydroxytoluene induced lung damage by oxygen: cell kinetics and collagen metabolism.
Am. Rev. Respir. Dis.
127:
28-34,
1983[Medline].
18.
Haschek, W. M.,
and
H. P. Witschi.
Pulmonary fibrosis: a possible mechanism.
Toxicol. Appl. Pharmacol.
51:
475-487,
1979[Medline].
19.
Kapanci, Y.,
E. R. Weibel,
H. P. Kaplan,
and
F. R. Robinson.
Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. II. Ultrastructural and morphometric studies.
Lab. Invest.
20:
101-118,
1969[Medline].
20.
Kauffman, S. L.
Cell proliferation in the mammalian lung.
Int. Rev. Exp. Pathol.
22:
131-191,
1980[Medline].
21.
Kawanami, O.,
V. Ferrans,
and
R. Crystal.
Structure of alveolar epithelial cells in patients with fibrotic lung disorders.
Lab. Invest.
46:
39-53,
1982[Medline].
22.
Kuhn, C., III,
J. Boldt,
T. E. King, Jr.,
E. Crouch,
T. Vartio,
and
J. A. McDonald.
An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis.
Am. Rev. Respir. Dis.
140:
1693-1703,
1989[Medline].
23.
Kuhn, C.,
and
J. A. McDonald.
The roles of the myofibroblast in idiopathic pulmonary fibrosis.
Am. J. Pathol.
138:
1257-1265,
1991[Abstract].
24.
Kuwano, K.,
R. Kunitake,
M. Kawasaki,
Y. Nomoto,
N. Hagimoto,
Y. Nakanishi,
and
N. Hara.
p21 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis.
Am. J. Respir. Crit. Care Med.
154:
477-483,
1996[Abstract].
25.
Mason, R.,
C. Leslie,
K. McCormick-Shannon,
R. Detering,
T. Nakamura,
J. Rubin,
and
J. Shannon.
Hepatocyte growth factor is a growth factor for rat alveolar type II cells.
Am. J. Respir. Cell Mol. Biol.
11:
561-567,
1994[Abstract].
26.
McDonald, J. A.
Idiopathic pulmonary fibrosis: a paradigm for lung injury and repair.
Chest
99:
87S-93S,
1991.
27.
Mundle, S.,
A. Iftikhar,
V. Shetty,
S. Alvi,
S. Dameron,
S. Gregory,
B. Marcus,
S. Khan,
and
A. Raza.
In situ end labeling of DNA to detect apoptotic cell death in a variety of human tumors.
Cell Death Differ.
1:
117-122,
1994.
28.
Panos, R. J.,
J. S. Rubin,
K. G. Csaky,
S. A. Aaronson,
and
R. J. Mason.
Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast conditioned medium.
J. Clin. Invest.
92:
969-977,
1993.
29.
Perez-Padilla, R.,
J. Salas,
R. Chapela,
G. Carrillo,
R. Sansores,
M. Gaxiola,
and
M. Selman.
Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia.
Am. Rev. Respir. Dis.
148:
49-53,
1993[Medline].
30.
Pick, R.,
J. Jalil,
J. Janicki,
and
K. Weber.
The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat.
Am. J. Pathol.
134:
365-371,
1989[Abstract].
31.
Polunovsky, V.,
B. Chen,
C. Henke,
D. Snover,
C. Wendt,
D. Ingbar,
and
P. Bitterman.
Role of mesenchymal cell death in lung remodeling after injury.
J. Clin. Invest.
92:
388-397,
1993.
32.
Selman, M.
Pulmonary fibrosis: human and experimental disease.
In: Connective Tissue in Health and Disease, edited by M. Rojkind. Boca Raton, FL: CRC, 1990, p. 123-188.
33.
Selman, M.,
M. Montano,
C. Ramos,
R. Barrios,
and
R. Perez-Tamayo.
Experimental pulmonary fibrosis induced by paraquat plus oxygen in rats: a morphologic and biochemical sequential study.
Exp. Mol. Pathol.
50:
147-166,
1989[Medline].
34.
Shannon, J. M.,
S. D. Jennings,
and
L. D. Nielsen.
Modulation of alveolar type II cell differentiated function in vitro.
Am. J. Physiol.
262 (Lung Cell. Mol. Physiol. 6):
L427-L436,
1992
35.
Simon, R. H.
Alveolar epithelial cells in pulmonary fibrosis.
In: Pulmonary Fibrosis, edited by S. H. Phan,
and R. S. Thrall. New York: Dekker, 1995, vol. 80, p. 511-540. (Lung Biol. Health Dis. Ser.)
36.
Tomei, L. D.,
and
F. O. Cope.
Apoptosis: the molecular basis of programmed cell death.
In: Current Communications in Cell and Molecular Biology. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1991.
37.
Uhal, B. D.
Cell cycle kinetics in the alveolar epithelium.
Am. J. Physiol.
272 (Lung Cell. Mol. Physiol. 16):
L1031-L1045,
1997
38.
Uhal, B. D.,
I. Joshi,
A. True,
S. Mundle,
A. Raza,
A. Pardo,
and
M. Selman.
Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro.
Am. J. Physiol.
269 (Lung Cell. Mol. Physiol. 13):
L819-L828,
1995
39.
Witschi, H.
Responses of the lung to toxic injury.
Environ. Health Perspect.
85:
5-13,
1990[Medline].
This article has been cited by other articles:
![]() |
E. Tourkina, M. Richard, P. Gooz, M. Bonner, J. Pannu, R. Harley, P. N. Bernatchez, W. C. Sessa, R. M. Silver, and S. Hoffman Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L843 - L861. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. He, H. Kubo, K. Ishizawa, A. E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya The role of the receptor for advanced glycation end-products in lung fibrosis Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1427 - L1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Willis and Z. Borok TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L525 - L534. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ramos, M. Montano, C. Becerril, J. Cisneros-Lira, L. Barrera, V. Ruiz, A. Pardo, and M. Selman Acidic fibroblast growth factor decreases {alpha}-smooth muscle actin expression and induces apoptosis in human normal lung fibroblasts Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L871 - L879. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, M. Molina-Molina, A. Abdul-Hafez, J. Ramirez, A. Serrano-Mollar, A. Xaubet, and B. D. Uhal Extravascular sources of lung angiotensin peptide synthesis in idiopathic pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L887 - L895. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marchand-Adam, A. Fabre, A. A. Mailleux, J. Marchal, C. Quesnel, H. Kataoka, M. Aubier, M. Dehoux, P. Soler, and B. Crestani Defect of Pro-Hepatocyte Growth Factor Activation by Fibroblasts in Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 58 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Plantier, S. Marchand-Adam, J. Marchal-Somme, G. Leseche, M. Fournier, M. Dehoux, M. Aubier, and B. Crestani Defect of hepatocyte growth factor production by fibroblasts in human pulmonary emphysema Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L641 - L647. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, R. Shu, G. Filippatos, and B. D. Uhal Apoptosis in lung injury and remodeling J Appl Physiol, October 1, 2004; 97(4): 1535 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ruiz, R. Ma. Ordonez, J. Berumen, R. Ramirez, B. Uhal, C. Becerril, A. Pardo, and M. Selman Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L1026 - L1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Kagan, G. G. Borisenko, B. F. Serinkan, Y. Y. Tyurina, V. A. Tyurin, J. Jiang, S. X. Liu, A. A. Shvedova, J. P. Fabisiak, W. Uthaisang, et al. Appetizing rancidity of apoptotic cells for macrophages: oxidation, externalization, and recognition of phosphatidylserine Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L1 - L17. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, H. Zhang, V. Soledad-Conrad, J. Zhuang, and B. D. Uhal Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L501 - L507. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Krein and B. W. Winston Roles for Insulin-Like Growth Factor I and Transforming Growth Factor-{beta} in Fibrotic Lung Disease Chest, December 1, 2002; 122(6_suppl): 289S - 293S. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bucchieri, S. M. Puddicombe, J. L. Lordan, A. Richter, D. Buchanan, S. J. Wilson, J. Ward, G. Zummo, P. H. Howarth, R. Djukanovic, et al. Asthmatic Bronchial Epithelium Is More Susceptible to Oxidant-Induced Apoptosis Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Crystal, P. B. Bitterman, B. Mossman, M. I. Schwarz, D. Sheppard, L. Almasy, H. A. Chapman, S. L. Friedman, T. E. King Jr., L. A. Leinwand, et al. Future Research Directions in Idiopathic Pulmonary Fibrosis: Summary of a National Heart, Lung, and Blood Institute Working Group Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 236 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Papp, X. Li, J. Zhuang, R. Wang, and B. D. Uhal Angiotensin receptor subtype AT1 mediates alveolar epithelial cell apoptosis in response to ANG II Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L713 - L718. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Filippatos, N. Gangopadhyay, O. Lalude, N. Parameswaran, S. I. Said, W. Spielman, and B. D. Uhal Regulation of apoptosis by vasoactive peptides Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L749 - L761. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Matute-Bello, C. W. Frevert, W. C. Liles, M. Nakamura, J. T. Ruzinski, K. Ballman, V. A. Wong, C. Vathanaprida, and T. R. Martin Fas/Fas Ligand System Mediates Epithelial Injury, but Not Pulmonary Host Defenses, in Response to Inhaled Bacteria Infect. Immun., September 1, 2001; 69(9): 5768 - 5776. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Matute-Bello, W. C. Liles, C. W. Frevert, M. Nakamura, K. Ballman, C. Vathanaprida, P. A. Kiener, and T. R. Martin Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L328 - L335. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. S. Brown, F. L. Harris, and D. M. Guidot Chronic ethanol ingestion potentiates TNF-{alpha}-mediated oxidative stress and apoptosis in rat type II cells Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L377 - L386. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ramos, M. Montaño, J. García-Alvarez, V. Ruiz, B. D. Uhal, M. Selman, and A. Pardo Fibroblasts from Idiopathic Pulmonary Fibrosis and Normal Lungs Differ in Growth Rate, Apoptosis, and Tissue Inhibitor of Metalloproteinases Expression Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 591 - 598. [Abstract] [Full Text] |
||||
![]() |
M. Kasper, C. Roehlecke, M. Witt, H. Fehrenbach, A. Hofer, T. Miyata, C. Weigert, R. H. W. Funk, and E. D. Schleicher Induction of Apoptosis by Glyoxal in Human Embryonic Lung Epithelial Cell Line L132 Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 485 - 491. [Abstract] [Full Text] |
||||
![]() |
A. Fine, Y. Janssen-Heininger, R. P. Soultanakis, S. G. Swisher, and B. D. Uhal Apoptosis in lung pathophysiology Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L423 - L427. [Abstract] [Full Text] [PDF] |
||||
![]() |
|